Top compounds associated with response to PSMD2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA barasertib CTRPv2 pan-cancer AAC -0.097 0.005
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.005
mRNA TAE684 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.1 0.006
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.006
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.21 0.006
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.088 0.008
mRNA decitabine CTRPv2 pan-cancer AAC -0.078 0.008
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.009
Download CSV